AB 1673 California Assembly · 2021-2022 Regular Session

California Fentanyl Abuse Task Force.

Summary
Existing law, the California Uniform Controlled Substances Act, classifies controlled substances into 5 schedules and places the greatest restrictions and penalties on the use of those substances placed in Schedule I. The act classifies the drug fentanyl in Schedule II. Existing law prohibits a person from possessing for sale or purchasing for purposes of sale, specified controlled substances, including fentanyl, and provides for imprisonment in a county jail for 2, 3, or 4 years for a violation of this provision. Existing law also requires a local health officer to assume that the fentanyl manufacturing process has led to some degree of chemical contamination and take action, as prescribed, if a fentanyl laboratory activity has taken place at a property. This bill would establish the California Fentanyl Abuse Task Force to undertake various duties relating to fentanyl abuse including, among others, collecting and organizing data on the nature and extent of fentanyl abuse in California and evaluating approaches to increase public awareness of fentanyl abuse. The bill would require the task force to be chaired by the Attorney General, or their designee, and would specify the membership of the task force. The bill would require the first meeting of the task force to take place no later than March 1, 2023, and would require the task force to meet at least once every 2 months. The bill would require the task force to report its findings and recommendations to the Attorney General, the Governor, and the Legislature by July 1, 2024. The bill would repeal these provisions on January 1, 2025.
Bill status in committee 1 of 4 stages cleared
Introduction
Jan 2022
Committee Review
Floor Vote
Governor
Introduced Jan 20, 2022 Last action May 19, 2022
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
11
Key actions
4
Committee
7
Amendments
3
May 19, 2022
Lower · Passed
In committee: Held under submission.
lower
May 11, 2022
Committee
In committee: Set, first hearing. Referred to suspense file.
lower
Apr 20, 2022
Lower · Passed
From committee: Do pass and re-refer to Com. on APPR. (Ayes 7. Noes 0.) (April 19). Re-referred to Com. on APPR.
lower
Apr 19, 2022
Committee
Re-referred to Com. on PUB. S.
lower
Apr 18, 2022
Introduced
From committee chair, with author's amendments: Amend, and re-refer to Com. on PUB. S. Read second time and amended.
lower
Mar 28, 2022
Committee
Re-referred to Com. on PUB. S.
lower
Mar 24, 2022
Lower · Passed
Read second time and amended.
lower
Mar 23, 2022
Introduced
From committee: Amend, and do pass as amended and re-refer to Com. on PUB. S. (Ayes 14. Noes 0.) (March 22).
lower
Jan 27, 2022
Committee
Referred to Coms. on HEALTH and PUB. S.
lower
Jan 21, 2022
Lower · Passed
From printer. May be heard in committee February 20.
lower
1 primary · 16 co-sponsors

Sponsors